Central Nervous Systems Therapeutic Drug Monitoring - Medical Devices Pipeline Assessment, 2019

Published by Global Data on 1st November 2019 | Ref: 1461242 | This Product Is In Stock

$2500 | Single User
$5000 | Site License
$7500 | Enterprise License
$2500 | Single User
$5000 | Site License
$7500 | Enterprise License

Introduction

Central Nervous Systems Therapeutic Drug Monitoring - Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, “Central Nervous Systems Therapeutic Drug Monitoring - Medical Devices Pipeline Assessment, 2019" provides an overview of Central Nervous Systems Therapeutic Drug Monitoring currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Central Nervous Systems Therapeutic Drug Monitoring pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Central Nervous Systems Therapeutic Drug Monitoring under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Central Nervous Systems Therapeutic Drug Monitoring and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry

Reasons to buy

The report enables you to -

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Central Nervous Systems Therapeutic Drug Monitoring under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

Table of Contents

1.1 List of Tables 4

1.2 List of Figures 5

2 Introduction 6

2.1 Central Nervous Systems Therapeutic Drug Monitoring Overview 6

3 Products under Development 7

3.1 Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Stage of Development 7

3.2 Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Territory 8

3.3 Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Regulatory Path 9

3.4 Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Estimated Approval Date 10

4 Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products under Development by Companies 11

4.1 Central Nervous Systems Therapeutic Drug Monitoring Companies - Pipeline Products by Stage of Development 11

4.2 Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Stage of Development 12

5 Central Nervous Systems Therapeutic Drug Monitoring Companies and Product Overview 13

5.1 Abbott Diagnostics Company Overview 13

5.2 ARK Diagnostics Inc Company Overview 14

5.3 Avacta Group Plc Company Overview 18

5.4 ELITechGroup Inc Company Overview 22

5.5 Nipro Europe N.V. Company Overview 25

5.6 Pax Neuroscience Inc Company Overview 26

5.7 Saladax Biomedical Inc Company Overview 27

5.8 Siemens Healthineers AG Company Overview 28

5.9 University of Colorado Company Overview 32

6 Central Nervous Systems Therapeutic Drug Monitoring- Recent Developments 33

6.1 Aug 29, 2019: Siemens Healthineers announces new Canadian leadership 33

6.2 Jul 29, 2019: Siemens Healthineers continues to drive growth forward 33

6.3 Jul 29, 2019: Changes in the Managing Board of Siemens Healthineers 34

6.4 May 02, 2019: Siemens Healthineers posts strong revenue and profit growth in the second quarter 35

6.5 Apr 09, 2019: Avacta Group: Interim results for the period ended 31 January 2019 36

6.6 Feb 11, 2019: Siemens Healthineers to invest EUR 350 million in new Campus Forchheim 38

6.7 Jan 28, 2019: Avacta Group names Dr. Sam Williams as Non-Executive Director to the Board 39

6.8 Jan 21, 2019: Avacta Group announced its AGM business update and notice of results 39

6.9 Dec 12, 2018: Avacta Group names Dr. Jose Saro as Chief Medical Officer 41

6.10 Dec 04, 2018: 10 Billion Lab Tests and Growing: Siemens Healthineers Mass. Manufacturing Expansion Largely Completed 41

6.11 Dec 04, 2018: 10 billion lab tests and growing: Siemens Healthineers mass. manufacturing expansion largely completed 43

6.12 Nov 05, 2018: Siemens Healthineers with strong finish in fourth quarter, full year targets for fiscal 2018 achieved 43

6.13 Oct 23, 2018: Leading Homegrown Medical Group, MWH Medical partners Siemens Healthineers to launch region’s first Asia Reference Centre 44

7 Appendix 46

7.1 Methodology 46

7.2 About GlobalData 49

7.3 Contact Us 49

7.4 Disclaimer 49

Additional Details

Publisher

Global Data

Publisher Information

Reference

1461242 | GDME0803EPD

Number of Pages

49

Report Format

PDF

This report is published by Global Data

Global Data deliver comprehensive, detailed market intelligence that provides a definitive picture of the markets they serve. Their data is complete, detailed, global and completely cross-country comparable.

With different types of data other providers don’t provide, our clients can access a variety of tools that add context to our core data including innovation tracking, sentiment analysis, price monitoring, M&A tracking, competitor intelligence, and city-level intelligence.

Download Free Report Summary PDF

Central Nervous Systems Therapeutic Drug Monitoring - Medical Devices Pipeline Assessment, 2019 | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.